PGXIS provides pharmacogenetics consultancy services, working with pharmaceutical and biotechnology companies to improve the development pipelines and cost-effectiveness of medicines. It offers a range of support for clients to design, implement and analyse pharmacogenomic studies including:

• Strategic and portfolio advice
• Study design and protocol preparation
• Ethical review and informed consent support and education
• Study management support
• Regulatory affairs support and interaction with             authorities
• Genomic data analysis (genetic statistics)
• Internal and external education/training delivery